Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
10,090
+1,250 (14.14%)
At close: Aug 28, 2026
KRX:019170 Revenue
Shinpoong Pharmaceutical Co.,Ltd had revenue of 63.89B KRW in the quarter ending June 30, 2026, with 8.99% growth. This brings the company's revenue in the last twelve months to 239.07B, up 6.21% year-over-year. In the year 2025, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 234.68B with 6.15% growth.
Revenue (ttm)
239.07B
Revenue Growth
+6.21%
P/S Ratio
1.91
Revenue / Employee
295.51M
Employees
809
Market Cap
457.33B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 234.68B | 13.59B | 6.15% |
| Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
| Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
| Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
| Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.12T |
| Dong-A Socio Holdings | 1.52T |
| Boryung | 1.06T |
| JW Holdings | 1.01T |
| Dong-A ST | 860.94B |
| JW Pharmaceutical | 820.86B |
| Huons | 616.80B |
| Ildong Pharmaceutical | 582.33B |